Clinical Trial Update: A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions [NA]

View source ↗

Summary

An update on a prospective pilot study evaluating OP-1 Putty for uninstrumented posterolateral fusion in degenerative lumbar spondylolisthesis; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Lumbar Spondylolisthesis

Drugs mentioned

• OP-1 Putty (recombinant human osteogenic protein-1 (OP-1) putty)

Snippet

Sponsor: Olympus Biotech Corporation | Conditions: Degenerative Lumbar Spondylolisthesis | NA | Status: COMPLETED